Position in GILD
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$28,546,649
-$2,337,464 QoQ
Shares Held
225,951
+2.0% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#280
of 2,266 holders
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026USS Investment Management Ltd holds $724,325,860 across 10 Drug Manufacturers - General names. GILD ranks #7 (3.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
1,014,246 | $257,588,056 | |
| 2 | LLY |
ELI LILLY & Co
|
139,687 | $167,544,792 | |
| 3 | ABBV |
AbbVie Inc.
|
300,376 | $75,586,616 | |
| 4 | MRK |
Merck & Co., Inc.
|
432,343 | $55,556,075 | |
| 5 | AZN |
Astrazeneca PLC
|
255,043 | $48,361,253 | |
| 6 | AMGN |
Amgen Inc
|
96,817 | $35,059,372 | |
| 7 | GILD |
Gilead Sciences, Inc.
This page
|
225,951 | $28,546,649 | |
| 8 | PFE |
Pfizer Inc
|
999,888 | $24,077,303 |
All Filings in GILD
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $28,546,649 | 225,951 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $30,884,113 | 221,598 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $26,120,544 | 212,812 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $23,622,132 | 212,812 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $23,594,466 | 212,812 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $24,201,007 | 215,984 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $19,957,646 | 216,062 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $20,512,965 | 244,668 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $16,230,450 | 236,561 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $16,832,410 | 229,794 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $18,005,930 | 222,268 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $18,920,701 | 252,478 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $18,417,186 | 238,967 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $19,827,091 | 238,967 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $20,392,293 | 237,534 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $12,893,703 | 209,008 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $18,155,945 | 293,738 | Shares | Sole | 2022-08-12 | |
| 2021-12-31 | $32,501,542 | 447,618 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $31,266,117 | 447,618 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $17,141,319 | 248,930 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $16,088,345 | 248,930 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $14,502,661 | 248,930 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $14,807,312 | 234,330 | Shares | Sole | 2020-10-30 | |
| 2020-06-30 | $18,029,350 | 234,330 | Shares | Sole | 2020-08-11 | |
| No filing history on record for this holder in this stock. | ||||||